Cancer Center, University of Virginia HSC

Charlottesville, Virginia 22908

0 studies enrolling now · 38 studies all time

What they study most

Brain Tumors, Brain and Central Nervous System Tumors, Breast Cancer, Cardiac Toxicity, Central Nervous System Tumors, Cervical Cancer, Diarrhea, Endometrial Cancer, Fallopian Tube Cancer, Head and Neck Cancer, Leukemia, Lymphoma

Studies at this site

• Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer — Completed
• Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy — Completed
• Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer — Completed
• Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus — Stopped early
• Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer — Stopped early
• Talc in Treating Patients With Malignant Pleural Effusion — Completed
• Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer — Completed
• Vaccine Therapy in Treating Patients With Metastatic Melanoma — Completed
• Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma — Completed
• Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma — Completed
• Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease — Completed
• Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma — Completed
• Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer — Completed
• Brachytherapy in Treating Patients With Prostate Cancer — Completed
• Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases — Completed
• Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer — Completed
• Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy — Status unconfirmed
• Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer — Status unconfirmed
• Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme — Completed
• Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix — Completed
• Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus — Stopped early
• Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer — Completed
• Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer — Completed
• Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer — Completed
• Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy — Completed
• Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer — Completed
• Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer — Stopped early
• Chemotherapy in Treating Patients With Sarcoma of the Uterus — Completed
• Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer — Completed
• Bexarotene in Treating Patients With Metastatic Breast Cancer — Completed
• Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer — Completed
• Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer — Completed
• Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer — Stopped early
• Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus — Stopped early
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer — Stopped early
• Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal — Completed
• Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia — Completed
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor — Completed